Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s “Revision” identifier was updated from v3.5.2 to v3.5.3. This reflects a platform/version update without changing the study record content shown.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a system-level version update and does not alter study content.SummaryDifference0.0%

- Check42 days agoChange DetectedPadua, Italy 35128 was removed from the locations and Padova, Italy 35128 was added to the locations.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a frontend build/version change with no visible alterations to study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 implemented, replacing the previous v3.4.2.SummaryDifference0.0%

- Check91 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 revision was removed, indicating an administrative update to study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.